Oracle and Oracle Red Bull Racing today announced a multi-year extension and expansion of their title partnership as the Team prepares for the most significant regulation shift in modern F1 history.
An Oppenheimer analyst has turned bullish on Oracle’s stock after a selloff that has wiped away more than half the company’s value since its September peak.
News this week covers a two-week period due to illness. Among the big security stories from that period, Substack announced the loss of user data, ...
Will unify health record systems with Oracle Health Foundation EHR, implement Oracle Health Clinical AI Agent and Oracle Health Seamless Exchange across its network Hillsboro Health provides emergency ...
PC game-download store GOG has come under scrutiny for using generative-AI in marketing artwork, then for seeming to sit on the fence in an answer about whether it will keep using the tech in the ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Azul, the only company 100% focused on Java, today released its global Oracle Java Usage, Pricing & Migration Survey and Report, conducted to assess the Java ...
Missouri’s new executive order (EO) on AI calls for the creation of a strategic framework to advance AI technology and related infrastructure, policy recommendations, and AI training program best ...
Advanced Micro Devices Inc (NASDAQ: AMD) shares plunged on Wednesday as chip stocks felt pressure following reports of a huge breakthrough in China's semiconductor ambitions and uncertainty around ...
Several bills related to food and beverage are among the measures lawmakers have advanced during the lame duck legislative session underway in Trenton. After a long recess beginning last June, both ...
The broader AI trade is back in the hot seat because of Oracle. It shouldn't be. Oracle shares were getting crushed on Thursday following a quarterly sales miss, a disappointing guide, and a spending ...
As the science of Crohn’s disease (CD) rapidly evolves, the American Gastroenterological Association (AGA) has issued a living guideline on the pharmacologic management of moderately to severely ...